Our focus will be advancing our quantum machine learning platform for cancer vaccine development to TRL 6 by accessing quantum hardware and simulators (via NQCC/Hartree Centre) and receiving specialist mentoring for hybrid algorithm optimisation, cloud integration, data security, and regulatory readiness. We will also develop our IP strategy and patent filings for our proprietary quantum encoders and models while building partnerships with IBM, IonQ, Rigetti, and research funders.

We aim further afield to scale product deployment, secure regulatory pathways and commercialise our product.

Address

Harwell Innovation Centre, Curie Avenue, Harwell Campus, OX11 0QG

Other organisations on campus